Avid Bioservices Inc
NASDAQ:CDMO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Takara Holdings Inc
TSE:2531
|
JP |
|
C
|
Cencora Inc
XBER:ABG
|
US |
|
e'grand Co Ltd
TSE:3294
|
JP |
|
A
|
Absa Group Ltd
JSE:ABG
|
ZA |
Avid Bioservices Inc
Total Liabilities
Avid Bioservices Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Total Liabilities
$278.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
38%
|
CAGR 10-Years
29%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$137.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$36.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$81.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Exact Sciences Corp
NASDAQ:EXAS
|
Total Liabilities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
57%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$7B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
Avid Bioservices Inc
Glance View
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
See Also
What is Avid Bioservices Inc's Total Liabilities?
Total Liabilities
278.7m
USD
Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Total Liabilities amounts to 278.7m USD.
What is Avid Bioservices Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
29%
Over the last year, the Total Liabilities growth was 2%. The average annual Total Liabilities growth rates for Avid Bioservices Inc have been 4% over the past three years , 38% over the past five years , and 29% over the past ten years .
